SLNO

Soleno Therapeutics INC

Insider trading activity for Soleno Therapeutics INC, straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

-$429.3K

net selling

Bought(0 · 0 insiders): $0
Sold(6 · 2 insiders): $429.3K

Transaction history

The 100 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
May 18	Sinclair Andrew	Director	DTOISS◆	10,000	—	—	—	Open the original filing on SEC.gov
May 18	Sinclair Andrew	Director	DTOISS◆	2,666	—	—	—	Open the original filing on SEC.gov
May 18	Sinclair Andrew	Director	DTOISS◆	2,666	—	—	—	Open the original filing on SEC.gov
May 18	Sinclair Andrew	Director	DTOISS◆	2,124	—	—	—	Open the original filing on SEC.gov
May 18	Sinclair Andrew	Director	DTOISS◆	2,666	—	—	—	Open the original filing on SEC.gov
May 18	Sinclair Andrew	Director	DTOISS◆	635	—	—	—	Open the original filing on SEC.gov
May 18	Sinclair Andrew	Director	DTOISS◆	823	—	—	—	Open the original filing on SEC.gov
May 18	Sinclair Andrew	Director	DTOISS◆	1,333	—	—	—	Open the original filing on SEC.gov
May 18	Sinclair Andrew	Director	DTOISS	10,491	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Volck Birgitte	Director	DTOISS◆	10,000	—	—	—	Open the original filing on SEC.gov
May 18	Volck Birgitte	Director	DTOISS◆	2,666	—	—	—	Open the original filing on SEC.gov
May 18	Volck Birgitte	Director	DTOISS◆	2,666	—	—	—	Open the original filing on SEC.gov
May 18	Volck Birgitte	Director	DTOISS◆	2,124	—	—	—	Open the original filing on SEC.gov
May 18	Volck Birgitte	Director	DTOISS◆	2,666	—	—	—	Open the original filing on SEC.gov
May 18	Volck Birgitte	Director	DTOISS◆	635	—	—	—	Open the original filing on SEC.gov
May 18	Volck Birgitte	Director	DTOISS◆	1,333	—	—	—	Open the original filing on SEC.gov
May 18	Volck Birgitte	Director	DTOISS	17,536	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS◆	11,900	—	—	—	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS◆	13,800	—	—	—	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS◆	16,000	—	—	—	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS◆	55,392	—	—	—	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS◆	11,667	—	—	—	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS◆	2,445	—	—	—	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS◆	18,800	—	—	—	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS◆	666	—	—	—	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS◆	4,000	—	—	—	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS◆	4,999	—	—	—	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS◆	1,741	—	—	—	Open the original filing on SEC.gov
May 18	Yen Kristen	See Remarks	DTOISS	37,639	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Pauls Matthew	Director	DTOISS◆	9,063	—	—	—	Open the original filing on SEC.gov
May 18	Pauls Matthew	Director	DTOISS	10,491	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Norrett Kevin	Chief Business Officer	DTOISS◆	4,000	—	—	—	Open the original filing on SEC.gov
May 18	Norrett Kevin	Chief Business Officer	DTOISS◆	64,286	—	—	—	Open the original filing on SEC.gov
May 18	Norrett Kevin	Chief Business Officer	DTOISS	17,786	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Manning Meredith	Chief Commercial Officer	DTOISS◆	32,800	—	—	—	Open the original filing on SEC.gov
May 18	Manning Meredith	Chief Commercial Officer	DTOISS◆	29,200	—	—	—	Open the original filing on SEC.gov
May 18	Manning Meredith	Chief Commercial Officer	DTOISS◆	91,000	—	—	—	Open the original filing on SEC.gov
May 18	Manning Meredith	Chief Commercial Officer	DTOISS	64,507	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Joshi Manher	Chief Development…	DTOISS◆	4,700	—	—	—	Open the original filing on SEC.gov
May 18	Joshi Manher	Chief Development…	DTOISS◆	72,321	—	—	—	Open the original filing on SEC.gov
May 18	Joshi Manher	Chief Development…	DTOISS	20,171	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Huang Michael F.	Sr. VP of Clinical…	DTOISS◆	11,900	—	—	—	Open the original filing on SEC.gov
May 18	Huang Michael F.	Sr. VP of Clinical…	DTOISS◆	13,800	—	—	—	Open the original filing on SEC.gov
May 18	Huang Michael F.	Sr. VP of Clinical…	DTOISS◆	110,000	—	—	—	Open the original filing on SEC.gov
May 18	Huang Michael F.	Sr. VP of Clinical…	DTOISS	39,823	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Hirano Patricia C	See Remarks	DTOISS◆	1,333	—	—	—	Open the original filing on SEC.gov
May 18	Hirano Patricia C	See Remarks	DTOISS◆	11,900	—	—	—	Open the original filing on SEC.gov
May 18	Hirano Patricia C	See Remarks	DTOISS◆	13,800	—	—	—	Open the original filing on SEC.gov
May 18	Hirano Patricia C	See Remarks	DTOISS◆	16,000	—	—	—	Open the original filing on SEC.gov
May 18	Hirano Patricia C	See Remarks	DTOISS◆	49,262	—	—	—	Open the original filing on SEC.gov
May 18	Hirano Patricia C	See Remarks	DTOISS◆	11,667	—	—	—	Open the original filing on SEC.gov
May 18	Hirano Patricia C	See Remarks	DTOISS◆	2,445	—	—	—	Open the original filing on SEC.gov
May 18	Hirano Patricia C	See Remarks	DTOISS◆	18,842	—	—	—	Open the original filing on SEC.gov
May 18	Hirano Patricia C	See Remarks	DTOISS◆	2,333	—	—	—	Open the original filing on SEC.gov
May 18	Hirano Patricia C	See Remarks	DTOISS	22,702	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Hahn Mark W	Director	DTOISS	10,046	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Fulk Jennifer	Chief Financial Officer	DTOISS◆	67,660	—	—	—	Open the original filing on SEC.gov
May 18	Fulk Jennifer	Chief Financial Officer	DTOISS	39,200	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Bir Dawn Carter	Director	DTOISS	16,991	—	—	-100.0%	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS◆	131,400	—	—	—	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS◆	115,600	—	—	—	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS◆	100,000	—	—	—	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS◆	200,753	—	—	—	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS◆	52,709	—	—	—	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS◆	73,333	—	—	—	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS◆	8,473	—	—	—	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS◆	35,000	—	—	—	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS◆	23,332	—	—	—	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS◆	60	—	—	—	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS◆	22,452	—	—	—	Open the original filing on SEC.gov
May 18	Anish Bhatnagar	Chief Executive Officer	DTOISS	583,656	—	—	-100.0%	Open the original filing on SEC.gov
Mar 27	Manning Meredith	Chief Commercial Officer	SSELL	558	$31.72	$17.7K	-0.9%	Open the original filing on SEC.gov
Mar 27	Manning Meredith	Chief Commercial Officer	SSELL	2,100	$31.04	$65.2K	-3.1%	Open the original filing on SEC.gov
Mar 27	Manning Meredith	Chief Commercial Officer	SSELL	4,864	$30.04	$146.1K	-6.8%	Open the original filing on SEC.gov
Mar 27	Huang Michael F.	Sr. VP of Clinical…	SSELL	488	$31.72	$15.5K	-1.2%	Open the original filing on SEC.gov
Mar 27	Huang Michael F.	Sr. VP of Clinical…	SSELL	1,838	$31.04	$57K	-4.4%	Open the original filing on SEC.gov
Mar 27	Huang Michael F.	Sr. VP of Clinical…	SSELL	4,256	$30.04	$127.8K	-9.2%	Open the original filing on SEC.gov
Mar 2	Fulk Jennifer	Chief Financial Officer	MEXER◆	67,660	—	—	—	Open the original filing on SEC.gov
Mar 2	Fulk Jennifer	Chief Financial Officer	AGRANT	39,200	—	—	—	Open the original filing on SEC.gov
Jan 21	Yen Kristen	See Remarks	AGRANT◆	11,900	—	—	—	Open the original filing on SEC.gov
Jan 21	Yen Kristen	See Remarks	AGRANT	10,400	—	—	+38.2%	Open the original filing on SEC.gov
Jan 21	Norrett Kevin	Chief Business Officer	AGRANT◆	4,000	—	—	—	Open the original filing on SEC.gov
Jan 21	Norrett Kevin	Chief Business Officer	AGRANT	3,500	—	—	+24.5%	Open the original filing on SEC.gov
Jan 21	Manning Meredith	Chief Commercial Officer	AGRANT◆	32,800	—	—	—	Open the original filing on SEC.gov
Jan 21	Manning Meredith	Chief Commercial Officer	AGRANT	28,600	—	—	+65.8%	Open the original filing on SEC.gov
Jan 21	Mackaness James H	Chief Financial Officer	AGRANT◆	32,800	—	—	—	Open the original filing on SEC.gov
Jan 21	Mackaness James H	Chief Financial Officer	AGRANT	28,600	—	—	+27.7%	Open the original filing on SEC.gov
Jan 21	Joshi Manher	Chief Development…	AGRANT◆	4,700	—	—	—	Open the original filing on SEC.gov
Jan 21	Joshi Manher	Chief Development…	AGRANT	4,100	—	—	+25.5%	Open the original filing on SEC.gov
Jan 21	Huang Michael F.	Sr. VP of Clinical…	AGRANT◆	11,900	—	—	—	Open the original filing on SEC.gov
Jan 21	Huang Michael F.	Sr. VP of Clinical…	AGRANT	10,400	—	—	+28.9%	Open the original filing on SEC.gov
Jan 21	Hirano Patricia C	See Remarks	AGRANT◆	11,900	—	—	—	Open the original filing on SEC.gov
Jan 21	Hirano Patricia C	See Remarks	AGRANT	10,400	—	—	+84.5%	Open the original filing on SEC.gov
Jan 21	Anish Bhatnagar	Chief Executive Officer	AGRANT◆	131,400	—	—	—	Open the original filing on SEC.gov
Jan 21	Anish Bhatnagar	Chief Executive Officer	AGRANT	114,200	—	—	+24.3%	Open the original filing on SEC.gov
Dec 15, 2025	Yen Kristen	See Remarks	FTAX	904	$49.95	$45.2K	-3.2%	Open the original filing on SEC.gov
Dec 15, 2025	Manning Meredith	Chief Commercial Officer	FTAX	1,922	$49.95	$96K	-4.2%	Open the original filing on SEC.gov
Dec 15, 2025	Mackaness James H	Chief Financial Officer	FTAX	2,013	$49.95	$100.5K	-1.9%	Open the original filing on SEC.gov
Dec 15, 2025	Huang Michael F.	Sr. VP of Clinical…	FTAX	812	$49.95	$40.6K	-2.2%	Open the original filing on SEC.gov
Dec 15, 2025	Hirano Patricia C	See Remarks	FTAX	904	$49.95	$45.2K	-6.9%	Open the original filing on SEC.gov

DTOISS◆—

Sinclair Andrew · DirectorMay 18

10,000 sh

DTOISS◆—

Sinclair Andrew · DirectorMay 18

2,666 sh

DTOISS◆—

Sinclair Andrew · DirectorMay 18

2,666 sh

DTOISS◆—

Sinclair Andrew · DirectorMay 18

2,124 sh

DTOISS◆—

Sinclair Andrew · DirectorMay 18

2,666 sh

DTOISS◆—

Sinclair Andrew · DirectorMay 18

635 sh

DTOISS◆—

Sinclair Andrew · DirectorMay 18

823 sh

DTOISS◆—

Sinclair Andrew · DirectorMay 18

1,333 sh

DTOISS—

Sinclair Andrew · DirectorMay 18

10,491 sh · -100.0% own

DTOISS◆—

Volck Birgitte · DirectorMay 18

10,000 sh

DTOISS◆—

Volck Birgitte · DirectorMay 18

2,666 sh

DTOISS◆—

Volck Birgitte · DirectorMay 18

2,666 sh

DTOISS◆—

Volck Birgitte · DirectorMay 18

2,124 sh

DTOISS◆—

Volck Birgitte · DirectorMay 18

2,666 sh

DTOISS◆—

Volck Birgitte · DirectorMay 18

635 sh

DTOISS◆—

Volck Birgitte · DirectorMay 18

1,333 sh

DTOISS—

Volck Birgitte · DirectorMay 18

17,536 sh · -100.0% own

DTOISS◆—

Yen Kristen · See RemarksMay 18

11,900 sh

DTOISS◆—

Yen Kristen · See RemarksMay 18

13,800 sh

DTOISS◆—

Yen Kristen · See RemarksMay 18

16,000 sh

DTOISS◆—

Yen Kristen · See RemarksMay 18

55,392 sh

DTOISS◆—

Yen Kristen · See RemarksMay 18

11,667 sh

DTOISS◆—

Yen Kristen · See RemarksMay 18

2,445 sh

DTOISS◆—

Yen Kristen · See RemarksMay 18

18,800 sh

DTOISS◆—

Yen Kristen · See RemarksMay 18

666 sh

DTOISS◆—

Yen Kristen · See RemarksMay 18

4,000 sh

DTOISS◆—

Yen Kristen · See RemarksMay 18

4,999 sh

DTOISS◆—

Yen Kristen · See RemarksMay 18

1,741 sh

DTOISS—

Yen Kristen · See RemarksMay 18

37,639 sh · -100.0% own

DTOISS◆—

Pauls Matthew · DirectorMay 18

9,063 sh

DTOISS—

Pauls Matthew · DirectorMay 18

10,491 sh · -100.0% own

DTOISS◆—

Norrett Kevin · Chief Business…May 18

4,000 sh

DTOISS◆—

Norrett Kevin · Chief Business…May 18

64,286 sh

DTOISS—

Norrett Kevin · Chief Business…May 18

17,786 sh · -100.0% own

DTOISS◆—

Manning Meredith · Chief Commercial…May 18

32,800 sh

DTOISS◆—

Manning Meredith · Chief Commercial…May 18

29,200 sh

DTOISS◆—

Manning Meredith · Chief Commercial…May 18

91,000 sh

DTOISS—

Manning Meredith · Chief Commercial…May 18

64,507 sh · -100.0% own

DTOISS◆—

Joshi Manher · Chief Development…May 18

4,700 sh

DTOISS◆—

Joshi Manher · Chief Development…May 18

72,321 sh

DTOISS—

Joshi Manher · Chief Development…May 18

20,171 sh · -100.0% own

DTOISS◆—

Huang Michael F. · Sr. VP of Clinical…May 18

11,900 sh

DTOISS◆—

Huang Michael F. · Sr. VP of Clinical…May 18

13,800 sh

DTOISS◆—

Huang Michael F. · Sr. VP of Clinical…May 18

110,000 sh

DTOISS—

Huang Michael F. · Sr. VP of Clinical…May 18

39,823 sh · -100.0% own

DTOISS◆—

Hirano Patricia C · See RemarksMay 18

1,333 sh

DTOISS◆—

Hirano Patricia C · See RemarksMay 18

11,900 sh

DTOISS◆—

Hirano Patricia C · See RemarksMay 18

13,800 sh

DTOISS◆—

Hirano Patricia C · See RemarksMay 18

16,000 sh

DTOISS◆—

Hirano Patricia C · See RemarksMay 18

49,262 sh

DTOISS◆—

Hirano Patricia C · See RemarksMay 18

11,667 sh

DTOISS◆—

Hirano Patricia C · See RemarksMay 18

2,445 sh

DTOISS◆—

Hirano Patricia C · See RemarksMay 18

18,842 sh

DTOISS◆—

Hirano Patricia C · See RemarksMay 18

2,333 sh

DTOISS—

Hirano Patricia C · See RemarksMay 18

22,702 sh · -100.0% own

DTOISS—

Hahn Mark W · DirectorMay 18

10,046 sh · -100.0% own

DTOISS◆—

Fulk Jennifer · Chief Financial…May 18

67,660 sh

DTOISS—

Fulk Jennifer · Chief Financial…May 18

39,200 sh · -100.0% own

DTOISS—

Bir Dawn Carter · DirectorMay 18

16,991 sh · -100.0% own

DTOISS◆—

Anish Bhatnagar · Chief Executive…May 18

131,400 sh

DTOISS◆—

Anish Bhatnagar · Chief Executive…May 18

115,600 sh

DTOISS◆—

Anish Bhatnagar · Chief Executive…May 18

100,000 sh

DTOISS◆—

Anish Bhatnagar · Chief Executive…May 18

200,753 sh

DTOISS◆—

Anish Bhatnagar · Chief Executive…May 18

52,709 sh

DTOISS◆—

Anish Bhatnagar · Chief Executive…May 18

73,333 sh

DTOISS◆—

Anish Bhatnagar · Chief Executive…May 18

8,473 sh

DTOISS◆—

Anish Bhatnagar · Chief Executive…May 18

35,000 sh

DTOISS◆—

Anish Bhatnagar · Chief Executive…May 18

23,332 sh

DTOISS◆—

Anish Bhatnagar · Chief Executive…May 18

60 sh

DTOISS◆—

Anish Bhatnagar · Chief Executive…May 18

22,452 sh

DTOISS—

Anish Bhatnagar · Chief Executive…May 18

583,656 sh · -100.0% own

SSELL$17.7K

Manning Meredith · Chief Commercial…Mar 27

558 sh @ $31.72 · -0.9% own

SSELL$65.2K

Manning Meredith · Chief Commercial…Mar 27

2,100 sh @ $31.04 · -3.1% own

SSELL$146.1K

Manning Meredith · Chief Commercial…Mar 27

4,864 sh @ $30.04 · -6.8% own

SSELL$15.5K

Huang Michael F. · Sr. VP of Clinical…Mar 27

488 sh @ $31.72 · -1.2% own

SSELL$57K

Huang Michael F. · Sr. VP of Clinical…Mar 27

1,838 sh @ $31.04 · -4.4% own

SSELL$127.8K

Huang Michael F. · Sr. VP of Clinical…Mar 27

4,256 sh @ $30.04 · -9.2% own

MEXER◆—

Fulk Jennifer · Chief Financial…Mar 2

67,660 sh

AGRANT—

Fulk Jennifer · Chief Financial…Mar 2

39,200 sh

AGRANT◆—

Yen Kristen · See RemarksJan 21

11,900 sh

AGRANT—

Yen Kristen · See RemarksJan 21

10,400 sh · +38.2% own

AGRANT◆—

Norrett Kevin · Chief Business…Jan 21

4,000 sh

AGRANT—

Norrett Kevin · Chief Business…Jan 21

3,500 sh · +24.5% own

AGRANT◆—

Manning Meredith · Chief Commercial…Jan 21

32,800 sh

AGRANT—

Manning Meredith · Chief Commercial…Jan 21

28,600 sh · +65.8% own

AGRANT◆—

Mackaness James H · Chief Financial…Jan 21

32,800 sh

AGRANT—

Mackaness James H · Chief Financial…Jan 21

28,600 sh · +27.7% own

AGRANT◆—

Joshi Manher · Chief Development…Jan 21

4,700 sh

AGRANT—

Joshi Manher · Chief Development…Jan 21

4,100 sh · +25.5% own

AGRANT◆—

Huang Michael F. · Sr. VP of Clinical…Jan 21

11,900 sh

AGRANT—

Huang Michael F. · Sr. VP of Clinical…Jan 21

10,400 sh · +28.9% own

AGRANT◆—

Hirano Patricia C · See RemarksJan 21

11,900 sh

AGRANT—

Hirano Patricia C · See RemarksJan 21

10,400 sh · +84.5% own

AGRANT◆—

Anish Bhatnagar · Chief Executive…Jan 21

131,400 sh

AGRANT—

Anish Bhatnagar · Chief Executive…Jan 21

114,200 sh · +24.3% own

FTAX$45.2K

Yen Kristen · See RemarksDec 15, 2025

904 sh @ $49.95 · -3.2% own

FTAX$96K

Manning Meredith · Chief Commercial…Dec 15, 2025

1,922 sh @ $49.95 · -4.2% own

FTAX$100.5K

Mackaness James H · Chief Financial…Dec 15, 2025

2,013 sh @ $49.95 · -1.9% own

FTAX$40.6K

Huang Michael F. · Sr. VP of Clinical…Dec 15, 2025

812 sh @ $49.95 · -2.2% own

FTAX$45.2K

Hirano Patricia C · See RemarksDec 15, 2025

904 sh @ $49.95 · -6.9% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 27 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More healthcare services companies

Other issuers in the same industry with insider filings on record.

Whole sector →